Craig Wong-Pan
Stock Analyst at RBC Capital
(0.69)
# 3,887
Out of 4,429 analysts
298
Total ratings
43.8%
Success rate
-2.9%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Maintained: Hold | $113.00 → $107.00 | $112.11 | -4.56% | 32 | Jun 15, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $25.00 → $23.00 | $19.71 | +16.72% | 24 | Jun 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.75 → $0.72 | $0.71 | +1.41% | 13 | Jun 11, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.20 → $3.05 | $1.94 | +57.62% | 21 | May 28, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Hold | $37.87 → $34.00 | $38.22 | -11.04% | 4 | May 26, 2026 | |
| ASX: REG Regis Healthcare Limited | Upgraded: Buy | $8.00 → $7.50 | $6.21 | +20.77% | 27 | May 25, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Hold | $0.12 → $0.13 | $0.098 | +32.65% | 22 | May 18, 2026 | |
| ASX: HLS Healius Limited | Downgraded: Sell | $0.75 → $0.35 | $0.38 | -7.89% | 29 | May 13, 2026 | |
| RMD ResMed | Maintained: Buy | $311 → $321 | $188.63 | +70.17% | 34 | May 1, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $297.00 → $125.00 | $113.81 | +9.83% | 20 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $14.14 | +27.30% | 5 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36.00 → $45.00 | $39.76 | +13.19% | 21 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.00 → $3.75 | $3.29 | +13.98% | 17 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 | $30.18 | +35.87% | 7 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.80 → $2.40 | $2.22 | +8.35% | 19 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16.04 | $27.01 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31.60 | $12.99 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $22.76 | n/a | 1 | May 22, 2019 |
CSL Limited
Jun 15, 2026
Maintained: Hold
Price Target: $113.00 → $107.00
Current: $112.11
Upside: -4.56%
Sonic Healthcare Limited
Jun 15, 2026
Maintained: Hold
Price Target: $25.00 → $23.00
Current: $19.71
Upside: +16.72%
Monash IVF Group Limited
Jun 11, 2026
Maintained: Hold
Price Target: $0.75 → $0.72
Current: $0.71
Upside: +1.41%
Integral Diagnostics Limited
May 28, 2026
Maintained: Buy
Price Target: $3.20 → $3.05
Current: $1.94
Upside: +57.62%
Fisher & Paykel Healthcare Corporation Limited
May 26, 2026
Upgraded: Hold
Price Target: $37.87 → $34.00
Current: $38.22
Upside: -11.04%
Regis Healthcare Limited
May 25, 2026
Upgraded: Buy
Price Target: $8.00 → $7.50
Current: $6.21
Upside: +20.77%
Alcidion Group Limited
May 18, 2026
Maintained: Hold
Price Target: $0.12 → $0.13
Current: $0.098
Upside: +32.65%
Healius Limited
May 13, 2026
Downgraded: Sell
Price Target: $0.75 → $0.35
Current: $0.38
Upside: -7.89%
ResMed
May 1, 2026
Maintained: Buy
Price Target: $311 → $321
Current: $188.63
Upside: +70.17%
Cochlear Limited
Apr 22, 2026
Maintained: Buy
Price Target: $297.00 → $125.00
Current: $113.81
Upside: +9.83%
Apr 15, 2026
Maintained: Buy
Price Target: $18.00
Current: $14.14
Upside: +27.30%
Feb 26, 2026
Maintained: Hold
Price Target: $36.00 → $45.00
Current: $39.76
Upside: +13.19%
Feb 24, 2026
Maintained: Hold
Price Target: $4.00 → $3.75
Current: $3.29
Upside: +13.98%
Feb 16, 2026
Maintained: Buy
Price Target: $41.00
Current: $30.18
Upside: +35.87%
Feb 16, 2026
Maintained: Hold
Price Target: $2.80 → $2.40
Current: $2.22
Upside: +8.35%
Oct 6, 2020
Maintained: Sell
Price Target: $16.04
Current: $27.01
Upside: n/a
Oct 6, 2020
Maintained: Buy
Price Target: $31.60
Current: $12.99
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $22.76
Upside: n/a